#Sustainability #India #Mumbai #Lupin Limited #Time Statista

Lupin Limited Recognized for Excellence in Sustainability

In a remarkable acknowledgment of its commitment to sustainable practices, Lupin Limited has officially entered the TIME and Statista list of the World's Most Sustainable Companies for the year 2026. This prestigious recognition highlights Lupin's ongoing efforts in environmental stewardship, ethical governance, and positive societal impact.

Global pharma leader Lupin is now ranked 318th among a competitive group of 750 organizations selected from over 5,000 of the world's largest companies. The selection process involved a thorough assessment across more than 20 indicators, including sustainability commitments, reporting transparency, and both environmental and social performance. Notably, Lupin stands alongside 15 other Indian companies that made it to this esteemed list, marking a significant milestone for Indian corporations on the global stage.

Ramesh Swaminathan, the Executive Director and Global CFO of Lupin, expressed enthusiasm for the recognition, stating, "Our inclusion in TIME and Statista's World's Most Sustainable Companies 2026 marks an important recognition for us. Sustainability is central to how we drive performance while advancing our purpose. We remain committed to accelerating our climate transition, strengthening governance and transparency, scaling renewable energy, and integrating ESG (Environmental, Social, and Governance) enterprise-wide."

This strong commitment to sustainable operations is not merely for show; it is deeply integrated into Lupin's business strategy. The recognition highlights the company's sustained efforts to merge ESG priorities into its global operations, working diligently to create long-term value for patients, communities, and other stakeholders. This is complemented by Lupin's noteworthy ESG performance, which includes receiving the highest 'A' leadership rating from CDP (Carbon Disclosure Project) for both Climate Change and Water Security. In 2025, the company's score in the SP Global Corporate Sustainability Assessment was an impressive 91, further reinforcing its standing in the global arena.

About Lupin Limited

Founded in Mumbai, India, Lupin Limited has grown into a global pharmaceutical giant with products available in more than 100 markets around the world. The company specializes in a wide range of pharmaceutical products, including both branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Its reputation as a trusted provider extends to healthcare professionals and consumers, particularly in India and the United States, across various therapeutic areas such as respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women's health.

Lupin operates 15 state-of-the-art manufacturing sites and 7 research centers globally, supported by a dedicated workforce of over 24,000 professionals. With subsidiaries like Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions, the company is devoted to enhancing patient health outcomes.

So why does this matter? As more companies face the pressing need for sustainability, Lupin serves as a template for success. Its strategy demonstrates that sustainable practices can align with corporate performance, paving the way for others in the industry. As the push toward sustainability accelerates in the global business community, Lupin's recognition not only validates its strides but also inspires ongoing commitment within the pharmaceutical sector and beyond.

For more information about Lupin's products and initiatives, visit www.lupin.com or follow the company on LinkedIn at Lupin LinkedIn.